Table 1.
Characteristics | n (%) | Median (Range) |
---|---|---|
Patient | ||
Gender | ||
Male | 10 (71) | |
Female | 4 (29) | |
Age (y) | 57 (40, 78) | |
Surgery before BNCT | ||
Yes | 8 (57) | |
No | 6 (43) | |
Prior cumulative RT dose (Gy) | 68 (60, 102) | |
Time from prior RT to BNCT (mo) | 23 (8, 108) | |
Tumor | ||
Primary site | ||
Oral cavity | 7 (50) | |
Nasopharynx | 2 (14) | |
Oropharynx | 2 (14) | |
Hypopharynx | 1 (7) | |
Parotid gland | 1 (7) | |
Mandible | 1 (7) | |
Pathology | ||
SCC | 10 (71) | |
Other carcinoma * | 3 (21) | |
Sarcoma | 1 (7) | |
Volume (cc) | 13.5 (3.1, 368) | |
Recurrent T stage | ||
rT0 | 1 (7) | |
rT1 | 0 (0) | |
rT2 | 1 (7) | |
rT3 | 6 (43) | |
rT4 | 6 (43) | |
Recurrent N stage | ||
rN0 | 9 (64) | |
rN1 | 2 (14) | |
rN2 | 3 (21) | |
rN3 | 0 (0) |
RT, radiotherapy; BNCT, boron neutron capture therapy; mo, months; SCC, squamous cell carcinoma. * Other carcinoma includes mucoepidermoid carcinoma and non-keratinizing carcinoma.